Total Valuation
Stella Diagnostics has a market cap or net worth of $2.43M. The enterprise value is $13.43M.
Market Cap$2.43M
Enterprise Value$13.43M
Share Statistics
Stella Diagnostics has 301,505,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding301,505,430
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Stella Diagnostics’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 23.95%.
Return on Equity (ROE)0.15
Return on Assets (ROA)-23.54
Return on Invested Capital (ROIC)23.95%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee891.91K
Profits Per Employee-2.03M
Employee Count2
Asset Turnover10.35
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Stella Diagnostics is ―. Stella Diagnostics’s PEG ratio is -0.00477.
PE Ratio―
PS Ratio3.00
PB Ratio-0.20
Price to Fair Value-0.20
Price to FCF-4.12
Price to Operating Cash Flow-0.91
PEG Ratio-0.00477
Income Statement
In the last 12 months, Stella Diagnostics had revenue of 1.78M and earned -4.06M in profits. Earnings per share was -0.01.
Revenue1.78M
Gross Profit-660.29K
Operating Income-3.45M
Pretax Income-4.06M
Net Income-4.06M
EBITDA-3.45M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.70M and capital expenditures -4.00, giving a free cash flow of -1.70M billion.
Operating Cash Flow-1.70M
Free Cash Flow-1.70M
Free Cash Flow per Share>-0.01
Dividends & Yields
Stella Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.48
52-Week Price Change-71.43%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)4.22
Average Volume (3m)1.09K
Important Dates
Stella Diagnostics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Stella Diagnostics as a current ratio of <0.01, with Debt / Equity ratio of -14.26%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap2.33
Net Debt to EBITDA-3.60
Interest Coverage Ratio-5.65
Taxes
In the past 12 months, Stella Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Stella Diagnostics EV to EBITDA ratio is -5.16, with an EV/FCF ratio of -13.68.
EV to Sales9.97
EV to EBITDA-5.16
EV to Free Cash Flow-13.68
EV to Operating Cash Flow-13.68
Balance Sheet
Stella Diagnostics has $32.22K in cash and marketable securities with $3.99M in debt, giving a net cash position of -$3.96M billion.
Cash & Marketable Securities$32.22K
Total Debt$3.99M
Net Cash-$3.96M
Net Cash Per Share-$0.01
Tangible Book Value Per Share-$0.08
Margins
Gross margin is -34.49%, with operating margin of -193.24%, and net profit margin of -227.47%.
Gross Margin-34.49%
Operating Margin-193.24%
Pretax Margin-227.47%
Net Profit Margin-227.47%
EBITDA Margin-193.24%
EBIT Margin-193.24%
Analyst Forecast
The average price target for Stella Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast774.05%
EPS Growth Forecast-258.97%